Literature DB >> 30817255

Potential Strategies for Clinical Translation of Repeated Cell Therapy.

Bojan Vrtovec1, Roberto Bolli2.   

Abstract

Entities:  

Keywords:  cardiomyopathy, dilated; cell- and tissue-based therapy; clinical trial; heart failure; myocardial ischemia

Mesh：

Year:  2019        PMID： 30817255      PMCID： PMC6400294          DOI： 10.1161/CIRCRESAHA.118.314653

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  4 in total

1.  Echocardiography-guided percutaneous left ventricular intracavitary injection as a cell delivery approach in infarcted mice.

Authors:  Yibing Nong; Yiru Guo; Alex Tomlin; Xiaoping Zhu; Marcin Wysoczynski; Qianhong Li; Roberto Bolli
Journal:  Mol Cell Biochem       Date:  2021-02-05       Impact factor: 3.396

2.  Multiple Intravenous Injections of Valproic Acid-Induced Mesenchymal Stem Cell from Human-Induced Pluripotent Stem Cells Improved Cardiac Function in an Acute Myocardial Infarction Rat Model.

Authors:  Shuyuan Guo; Yusen Zhang; Yanmin Zhang; Fanhua Meng; Minghua Li; Zhendong Yu; Yun Chen; Guanghui Cui
Journal:  Biomed Res Int       Date:  2020-12-17       Impact factor: 3.411

3.  Cardiopoietic stem cell therapy in ischaemic heart failure: long-term clinical outcomes.

Authors:  Jozef Bartunek; Andre Terzic; Beth A Davison; Atta Behfar; Ricardo Sanz-Ruiz; Wojciech Wojakowski; Warren Sherman; Guy R Heyndrickx; Marco Metra; Gerasimos S Filippatos; Scott A Waldman; John R Teerlink; Timothy D Henry; Bernard J Gersh; Roger Hajjar; Michal Tendera; Stefanie Senger; Gad Cotter; Thomas J Povsic; William Wijns
Journal:  ESC Heart Fail       Date:  2020-10-23

Review 4.  Cell therapy in patients with heart failure: a comprehensive review and emerging concepts.

Authors:  Roberto Bolli; Mitesh Solankhi; Xiang-Liang Tang; Arunpreet Kahlon
Journal:  Cardiovasc Res       Date:  2022-03-16       Impact factor: 10.787
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.